Can a Hawaii resident get peptides by telehealth?
HRS 453-1.3 lets a physician practice telehealth within the scope of the physician's license. Subsection (e) says a physician-patient relationship may be established via a telehealth interaction, provided the physician holds a Hawaii medical license, and once a relationship exists the patient or physician may use telehealth for any authorized purpose. Telehealth services must include a documented patient evaluation, with history and a discussion of physical symptoms, adequate to establish a diagnosis and identify contraindications, and a prescription issued by telehealth is held to the same standard as traditional settings. Subsection (c) states that issuing a prescription based solely on an online questionnaire is not treatment and is not an acceptable standard of care. For opiates the relationship must start with an in-person consultation, with a narrow three-day exception inside the same medical group; peptides in this database are not opiates. Standard telephone calls, fax, and e-mail text are not telehealth unless delivered through an interactive telecommunications system. Subsections (c), (h), and (j) are scheduled for repeal and reenactment on December 31, 2027. This record classifies asynchronous prescribing as allowed because subsection (j) defines telehealth to include store and forward technologies and secure asynchronous information exchange used for establishing a physician-patient relationship, evaluating a patient, or treating a patient, and the statute sets no real-time requirement; a questionnaire alone is still not enough. [2]
How does the Hawaii pharmacy board treat compounding?
| Board | Hawaii State Board of Pharmacy (Department of Commerce and Consumer Affairs) |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The Hawaii State Board of Pharmacy, part of the Professional and Vocational Licensing Division of the Department of Commerce and Consumer Affairs, regulates pharmacies under HRS chapter 461. Hawaii has no separate state bulks list, so peptide eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). HRS 461-14 makes it unlawful to operate a pharmacy in Hawaii without a Board permit, and HRS 461-15 requires any out-of-state pharmacy that ships, mails, or delivers prescription drugs into Hawaii to first obtain a Board permit, disclosing its principal officers, attesting to no drug law violations, keeping its home-state license in good standing, and employing a registered pharmacist in good standing. The Board's rules are Hawaii Administrative Rules chapter 16-95 (Pharmacists and Pharmacies). HAR 16-95-110(a)(17) makes failure to comply with the compounding requirements in USP chapters 795 (nonsterile preparations) and 797 (sterile preparations) a ground for discipline; the chapter has no separate compounding subchapter. [1] [3] [4] [6]
Can you get compounded GLP-1s in Hawaii?
Because Hawaii rejects questionnaire-only prescribing, patients using national telehealth GLP-1 programs should expect a documented evaluation by a Hawaii-licensed physician, and any out-of-state pharmacy must hold a Hawaii out-of-state pharmacy permit. [2] [3] [9]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in Hawaii?
Access options
Prescriber licensed in Hawaii, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in Hawaii. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. State law says an online questionnaire alone is not enough.
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
CJC-1295 / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $220/month
Tesamorelin / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $274/month
Semax / Selank from Bodybuilding Peptides
SponsoredPartner lists from $274/month
We may earn a commission from these links.
Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.
Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.
Find a provider in Hawaii
What you'll actually find in Hawaii, and how to check
Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [13] [14] [15]
No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [16]
What Hawaii has done
PeptideAgent has not found a board or legislative action on peptides in Hawaii.
Other states have acted:
- On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [18] Mississippi law
- Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [19] [20] Louisiana law
Checking the prescriber
Telehealth prescribing of non-controlled peptides is permitted in Hawaii. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. State law says an online questionnaire alone is not enough. [2] The telehealth rule in full.
Checking the pharmacy
Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Hawaii State Board of Pharmacy (Department of Commerce and Consumer Affairs); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [17]
If you're going ahead anyway
These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [16]
They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [7] [21] [22]
Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [17] [23] [24]
What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [15] [24] [25]
Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [16] [26] [27] [28] [29] [30]
Check for:
- A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [16]
- A real evaluation by a licensed prescriber, not just an online form.
- A certificate of analysis for the specific batch.
Questions to ask
- Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [17]
- Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [15]
- Pharmacy: Is this made for me on a prescription written in my name? [25]
- Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [15] [24]
- Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [15]
What is offered for a specific peptide, and what FDA found, is on each peptide page.
Is it legal to buy research peptides in Hawaii?
Only pharmacies permitted by the Hawaii Board of Pharmacy, including out-of-state pharmacies permitted under HRS 461-15, may dispense prescription drugs to Hawaii patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law and are not dispensed by a pharmacist. The Hawaii Food, Drug, and Cosmetic Act, HRS 328-17(a), separately bars any person from selling, delivering, holding for sale, or giving away a new drug unless an application for it has been approved under section 505 of the federal act (or, for a drug outside the federal act, filed with and not refused by the Hawaii director of health). [3] [5] [10]
Peptide-specific notes for Hawaii
| Peptide | Note |
|---|---|
| Semaglutide | Available branded by prescription from a Hawaii-licensed physician, including by telehealth after a documented evaluation; HRS 453-1.3 rejects prescriptions based solely on an online questionnaire. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [2] [9] |
Frequently asked questions
Can I get a GLP-1 prescription in Hawaii from an online questionnaire?
No. HRS 453-1.3 states that a prescription based solely on an online questionnaire is not acceptable care. A Hawaii-licensed physician can prescribe by telehealth after a documented evaluation with history and a discussion of symptoms adequate to reach a diagnosis and rule out contraindications. The statute does not require a live visit for this: its definition of telehealth includes store and forward technologies and secure asynchronous information exchange. [2]
Can a doctor licensed in another state start treating me in Hawaii by telehealth?
Only if the doctor also holds a Hawaii medical license. HRS 453-1.3(e) lets a physician-patient relationship be established by telehealth provided the physician has a license to practice medicine in Hawaii. [2]
What does a mainland pharmacy need to ship compounded peptides to Hawaii?
A Hawaii Board of Pharmacy permit for out-of-state pharmacies under HRS 461-15. The pharmacy must keep its home-state license in good standing, employ a registered pharmacist, and disclose its principal officers. Check the Professional and Vocational Licensing search before ordering. [1] [3]
Can a Hawaii pharmacy compound BPC-157?
Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: Hawaii has no separate state bulks list, so peptide eligibility follows the federal 503A framework. [7] [8] [11] [12]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.
- [1]Hawaii State Board of Pharmacy, Professional and Vocational Licensing Division
- [2]Hawaii Revised Statutes section 453-1.3, Practice of telehealth (Hawaii Legislature)
- [3]Hawaii Revised Statutes chapter 461, Pharmacists and pharmacy (including sections 461-14 and 461-15)
- [4]Hawaii Administrative Rules chapter 16-95, Pharmacists and Pharmacies (compilation, Board of Pharmacy)
- [5]Hawaii Revised Statutes section 328-17, New drugs, regulation of sale (Hawaii Legislature)
- [6]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [7]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
- [8]FDA: Pharmacy Compounding Advisory CommitteeFDA
- [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [10]21 U.S.C. 331, Prohibited acts
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, October 28). Are peptides legal in Hawaii?. https://peptideagent.ai/legal/hawaii- HTML link
<a href="https://peptideagent.ai/legal/hawaii">Are peptides legal in Hawaii?</a>, PeptideAgent, updated October 28, 2026.